X
Record #48194

Azoramide, a novel regulator, favors adipogenesis against osteogenesis through inhibiting the GLP-1 receptor-PKA-β-catenin pathway

Original paper date
Mar 9, 2018
Institution
State Key Laboratory of Cancer Biology, Department of Pharmacogenomics, Fourth Military Medical University, Xi’an 710032, People’s Republic of China · Institute of Urinary Surgery, Xijing Hospital, Fourth Military Medical University, Xi’an 710032, People’s Republic of China · Institute of Orthopedic Surgery, Xijing Hospital, Fourth Military Medical University, Xi’an 710032, People’s Republic of China · Infection and Immunity Program, Department of Microbiology, Biomedicine Discovery Institute, Monash University, Clayton, VIC 3800, Australia · Department of Occupational and Environmental Health and the Ministry of Education Key Lab of Hazard Assessment and Control in Special Operational Environment, School of Public Health, Fourth Military Medical University, Xi’an 710032, People’s Republic of China · School of Pharmacy, China Medical University, Liaoning 110122, China · Department of Pharmacology, Xi’an Medical University, Xi’an 710021, People’s Republic of China
Open access
No
Article type
Research Article
Broad categories
(BLS) Biochemistry(BLS) Biology - Cellular(BLS) Toxicology(HSC) Medicine - Pharmacology
Citation lifecycle

How this paper is being cited

Pre-retraction
9
Same day
0
Post-retraction
2
% post-retraction
18.2%
~1.6 citations/yr before retraction · ~0.7 citations/yr after
— citing papers

Who is still citing this work

Loading…
Back to browse